The US Food and Drug Administration (FDA) has granted approval for Innoblative Designs' investigational device exemption (IDE ...

Adagio Medical Holdings, Inc. (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that it has ...

Adagio Medical (Nasdaq:ADGM) announced today that it received FDA breakthrough device designation for its vCLAS cryoablation ...

Innoblative Designs announced today that it received FDA investigational device exemption (IDE) for its Sira RFA ...

US FDA grants IDE approval to Innoblative’s SIRA RFA electrosurgical device for breast cancer treatment: Chicago Monday, ...

Verafeye is a four-dimensional (4D), ultrasound-based cardiac visualisation and navigation platform that generates a ...

Upon completion of the study, the company plans to submit the OTTAVA system for De Novo authorization in the U.S.

Anaconda Biomed, SL, a developer of next-generation neurothrombectomy devices, recently announced the enrollment and ...

DelveInsight’s Cardiopulmonary Bypass Equipment Market Insightsreport provides the current and forecast market analysis, ...

With a focus on endovascular aneurysm repair (EVAR) for abdominal aortic aneurysms (AAAs) and thoracoabdominal aortic aneurysms ( ...